A Non-competitive Serpin-Like Thrombin Inhibitor Isolated from Moringa oleifera Exhibit a High Affinity for Thrombin
- PMID: 37149510
- DOI: 10.1007/s10930-023-10116-6
A Non-competitive Serpin-Like Thrombin Inhibitor Isolated from Moringa oleifera Exhibit a High Affinity for Thrombin
Abstract
The majority of the clotting factors involved in blood coagulation pathways are serine proteases and thrombin is one of the key serine proteases involved in blood clotting. Many synthetic and chemical drugs targeting these proteases as therapeutics are known. However, they are associated with serious side effects such as bleeding, haemorrhage, edema etc. Serine protease inhibitors from plants have been suggested as one of the potential anticoagulant molecules against thrombosis. In the present work, a direct thrombin inhibitor from Moringa oleifera was isolated, purified and characterized. The homogeneity of the inhibitor is confirmed on native- PAGE. The purified inhibitor (5 µg) showed 63% thrombin inhibition at pH 7.2 at 37 °C. The IC50 value of the isolated inhibitor was determined as 4.23 µg. The inhibitor on SDS-PAGE appeared as a single protein-stained band corresponding to 50 kDa thereby indicating its molecular weight as 50 kDa. Purified thrombin inhibitor (5 µg) showed 12% inhibition of trypsin, and 17% inhibition of chymotrypsin. This suggests more specificity of purified inhibitor towards thrombin. The isolated inhibitor showed a non-competitive mode of inhibition against thrombin as determined by the Dixon plot. The inhibition constant (Ki) was calculated as 4.35 × 10-7 M. The present work reports for the first time a direct thrombin inhibitor from M. oleifera which may be further explored as an antithrombotic drug.
Keywords: Antithrombotic; Moringa oleifera; Non-competitive inhibition; Thrombin inhibitor.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Fear G, Komarnytsky S, Raskin I (2007) Protease inhibitors and their peptidomimetic derivatives as potential drugs. Pharmacol Ther 113:354–368 - PubMed
-
- Chen YW, Huang SC, Lin-Shiau SY, Lin JK (2005) Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1. Carcinogenesis 26:1296–1306 - PubMed
-
- Magee PJ, Owusu-Apenten R, McCann MJ, Gill CI, Rowland IR (2012) Chickpea (Cicer arietinum) and other plant-derived protease inhibitor concentrates inhibit breast and prostate cancer cell proliferation in vitro. Nutr Cancer 64:741–748 - PubMed
-
- Sen S, Dutta SK (2012) Evaluation of anti-cancer potential of ragi bifunctional inhibitor (RBI) from Elusine coracana on human chronic myeloid leukemia cells. Eur J Plant Sci Biotechnol 6:103–108
-
- De Freitas MAG, Amaral NO, Alvares ADCM, De Oliveira SA, Mehdad A, Honda DE, De Freitas SM (2020) Blood pressure-lowering effects of a Bowman-Birk inhibitor and its derived peptides in normotensive and hypertensive rats. Sci Rep 10:1–15
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
